Trial · NCT01199744
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Any Adverse Drug Reaction | Relenza | 4 | participants | ||
| Number of Participants With Any Serious Adverse Drug Reaction (ADR) | Relenza | 1 | participants | ||
| Number of Male and Female Participants With Either a Serious or Non-serious Adverse Drug Reaction | Relenza | Male | 3 | participants | |
| Number of Male and Female Participants With Either a Serious or Non-serious Adverse Drug Reaction | Relenza | Female | 1 | participants | |
| Number of Participants in the Indicated Age Categories With Either a Serious or Non-serious Adverse Drug Reaction | Relenza | >=3 to <7 years | 0 | participants | |
| Number of Participants in the Indicated Age Categories With Either a Serious or Non-serious Adverse Drug Reaction | Relenza | >=7 to <15 years | 3 | participants | |
| Number of Participants in the Indicated Age Categories With Either a Serious or Non-serious Adverse Drug Reaction | Relenza | >=15 to <65 years | 1 | participants | |
| Number of Participants in the Indicated Age Categories With Either a Serious or Non-serious Adverse Drug Reaction | Relenza | >=65 to <74 years | 0 | participants | |
| Number of Participants With Either a Serious or Non-serious Adverse Drug Reaction Categorized by Reason for the Use of Relenza | Relenza | Treatment | 4 | participants | |
| Number of Participants With Either a Serious or Non-serious Adverse Drug Reaction Categorized by Reason for the Use of Relenza | Relenza | Prophylaxis | 0 | participants | |
| Number of Participants With Either a Serious or Non-serious Adverse Drug Reaction Categorized by Either Having Complications or Having no Complications | Relenza | Complications | 1 | participants | |
| Number of Participants With Either a Serious or Non-serious Adverse Drug Reaction Categorized by Either Having Complications or Having no Complications | Relenza | No complications | 3 | participants | |
| Number of Participants With Either a Serious or Non-serious Adverse Drug Reaction Categorized by Either Having Risk Factors for Influenza or Having no Risk Factors | Relenza | Risk factor | 1 | participants | |
| Number of Participants With Either a Serious or Non-serious Adverse Drug Reaction Categorized by Either Having Risk Factors for Influenza or Having no Risk Factors | Relenza | No risk factor | 3 | participants | |
| Number of Participants With Either a Serious or Non-serious Adverse Drug Reaction Who Were Also in the Indicated High-risk Categories | Relenza | Pregnant | 0 | participants | |
| Number of Participants With Either a Serious or Non-serious Adverse Drug Reaction Who Were Also in the Indicated High-risk Categories | Relenza | Infant (<7 years of age) | 0 | participants | |
| Number of Participants With Either a Serious or Non-serious Adverse Drug Reaction Who Were Also in the Indicated High-risk Categories | Relenza | Elderly (>=65 years of age) | 0 | participants | |
| Number of Participants With Either a Serious or Non-serious Adverse Drug Reaction Who Were Also in the Indicated High-risk Categories | Relenza | Chronic respiratory disease | 1 | participants | |
| Number of Participants With Either a Serious or Non-serious Adverse Drug Reaction Who Were Also in the Indicated High-risk Categories | Relenza | Cardiocirculatory disease | 0 | participants | |
| Number of Participants With Either a Serious or Non-serious Adverse Drug Reaction Who Were Also in the Indicated High-risk Categories | Relenza | Diabetes | 0 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01199744/results